Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 14    tags : Pharmaceuticals    save search
Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
ELDN | $1.85 -7.03% -7.57% 420K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.27% H: 4.09% C: -3.91%
pharmaceuticals financial results
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
RWAY | $12.57 -0.4% -0.4% 230K twitter stocktwits trandingview |
| | O: 0.08% H: 1.83% C: 0.0%
TCON | $1.97 -6.64% -7.11% 240K twitter stocktwits trandingview |
Health Technology
 | | O: -2.96% H: 0.0% C: -6.71%
IMAB | $1.81 0.56% 0.55% 340K twitter stocktwits trandingview |
Health Technology
 | | O: 3.33% H: 6.22% C: 4.29%
pharmaceuticals financial update results
TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
TFFP | $3.35 6.86% 6.42% 3.7K twitter stocktwits trandingview |
Health Technology
 | | O: -5.41% H: 2.86% C: -14.29%
pharmaceuticals financial update results
Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
Published: 2022-11-14 (Crawled : 21:00) - globenewswire.com
RVPH | $3.035 0.5% 0.49% 140K twitter stocktwits trandingview |
| | O: 0.0% H: 2.0% C: -20.44%
pharmaceuticals financial results
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 21:00) - globenewswire.com
ADMP | $0.7751 0.86% 2.6% 120K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 29.44% C: 19.44%
pharmaceuticals financial update results
CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
Published: 2022-11-14 (Crawled : 21:00) - biospace.com/
CASI | $2.24 -1.36% 10K twitter stocktwits trandingview |
Health Technology
 | | O: 0.51% H: 3.27% C: -5.03%
pharmaceuticals financial results
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research
Published: 2022-11-14 (Crawled : 15:00) - biospace.com/
MYMD | $2.54 0.8% 0.79% 18K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.92% H: 2.27% C: -6.82%
pharmaceuticals drug research publication phase 1
Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 14:00) - globenewswire.com
ADIL | $1.9 -12.44% -14.21% 310K twitter stocktwits trandingview |
Health Technology
 | | O: 1.68% H: 3.98% C: -2.33%
pharmaceuticals financial update results
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-11-14 (Crawled : 13:20) - biospace.com/
SYRS | $4.54 -3.81% -3.96% 260K twitter stocktwits trandingview |
Health Technology
 | | O: -1.76% H: 2.56% C: -6.39%
pharmaceuticals financial update results
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K twitter stocktwits trandingview |
Health Technology
 | | O: 3.76% H: 15.95% C: -2.07%
pharmaceuticals financial update results
Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: 0.79% H: 3.65% C: -12.5%
pharmaceuticals financial update results
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
CRNX | $42.98 -0.07% -0.07% 620K twitter stocktwits trandingview |
Health Technology
 | | O: -1.25% H: 4.52% C: 1.49%
pharmaceuticals financial update results
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
Published: 2022-11-14 (Crawled : 13:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.86% C: -3.15%
pharmaceuticals financial results
Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Fourth Quarter and Full Year Ended September 30, 2022
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K twitter stocktwits trandingview |
Health Technology
 | | O: 0.22% H: 3.86% C: 1.79%
pharmaceuticals conference year financial
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
 | | O: -12.61% H: 3.86% C: -28.83%
pharmaceuticals financial update results
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
 | | O: -12.61% H: 3.86% C: -28.83%
pharmaceuticals breast potential update cancer negative
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
UPC | $2.19 8.76% 95K twitter stocktwits trandingview |
Manufacturing
 | | O: -1.57% H: 4.0% C: 4.0%
pharmaceuticals nasdaq
Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase 3 Trial of STS101 for the Acute Treatment of Migraine
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
STSA | $1.1 -0.9% -0.91% 0 twitter stocktwits trandingview |
Health Technology
 | | O: -82.05% H: 0.0% C: 0.0%
sts101 treatment pharmaceuticals topline trial migraine
KalVista Pharmaceuticals Presents Patient-Focused Data at American College of Allergy, Asthma & Immunology (ACAAI) 2022 Meeting
Published: 2022-11-14 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K twitter stocktwits trandingview |
Health Technology
 | | O: 0.18% H: 0.54% C: -4.72%
pharmaceuticals immunology meeting
NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 12:00) - prnewswire.com
RLFTF | $1.43 11.45% 3.8K twitter stocktwits trandingview |
n/a
 | | O: 1.45% H: 0.0% C: -3.43%
NRXP 2 d | $3.08 1.99% 1.95% 230K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.0% H: 0.0% C: -9.99%
pharmaceuticals financial update results
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.